About
CrystalChip from Idylle Labs is a miniaturized device that integrates all steps from molecule crystallization to high-resolution structural analysis. Once injected within the chip, crystallizing agents diffuse into 8 parallel micro-channels, creating dynamic concentration gradients. This favorable convection-free environment triggers nucleation and growth of multiple high-quality crystals along the channels, homogeneous in size and quality, which can be soaked with ligands. The microfluidic format of the chip makes it possible to perform all kinds of crystal analyses in situ. However, manual imaging of CrystalChips using a microscope can be a significant bottleneck in large-scale crystallization studies, prompting the need for automation to support high-throughput imaging.
Formulatrix, renowned for its innovative automation solutions, addressed this need by optimizing the imaging process with its Rock Imagers to support the dimensions of Idylle crystallization chips. Moreover, these imagers can capture superior-quality images using various imaging modalities to provide flexibility to suit experimental needs.
Join us in this webinar to learn more about how combining the advantages of the microfluidic format with high-throughput imaging opens exciting perspectives in protein crystallization studies.
When
February 6th, 2025
Session 1
10:00 AM - 10:30 AM CET
(09:00 AM - 09:30 AM GMT)
Session 2
01:00 PM - 01:30 PM ET
(10:00 AM - 10:30 AM PT)
About the Speaker:
Agathe Lermant is currently working as a product manager at IDYLLE, where she is in charge of transforming lab innovations into practical tools to help scientists around the world. Before joining IDYLLE, she studied biotech engineering in Paris, France, and did her PhD at the University of Dundee, UK, as part of the iPlacenta European network. Her research focused on building miniaturized placenta-on-chip models based on stem cells cultured in microfluidic devices.
About the Speaker:
Hafsa Iftikhar is currently working at Formulatrix as an application scientist for protein crystallization. She received her Ph.D. in Biochemistry and Structural Biology with research focused on the Identification of new potential inhibitors targeting HCV and SARS-CoV-2. Before joining Formulatrix, she worked as a research fellow at Helmholtz Centre for Infection Research (HZI), Germany, and associate researcher at Lahore University of Management Sciences (LUMS), Pakistan.